Portfoliotracker

SIGA Technologies, Inc.

SIGA · NASDAQGM · Healthcare Drug Manufacturers - Specialty & Generic 38/100 D

2,850 $
▲ +0,110 (+4,01 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 13:43
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score38 / 100 Market cap205 mil. $ P/E– Forward P/E2,7 P/S3,9 P/B1,3 EV/EBITDA– Dividend yield21,05 % FCF yield– EPS0,01 $ Net margin1,3 % Return on equity0,4 % Beta1,04 Debt / equity0,00
52-week range 2,66 to 7,11
3-month average volume0,6 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Website
siga.com
Employees
49
Country
United States
Fiscal year end
31. 12.
Data since
10. 9. 1997

Explore further

Similar companies EBSRIGL

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account